Cynapsus Therapeutics Inc's ticker is and the CUSIP is 23257Y701.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,806,000 | +37.1% | 108,575 | 0.0% | 1.87% | +63.8% |
| Q1 2016 | $1,317,000 | -22.7% | 108,575 | -1.5% | 1.14% | +11.1% |
| Q4 2015 | $1,703,000 | -71.3% | 110,226 | -70.0% | 1.03% | -32.4% |
| Q3 2015 | $5,940,000 | +0.8% | 367,427 | 0.0% | 1.52% | -8.4% |
| Q2 2015 | $5,892,000 | +15.1% | 367,427 | -93.8% | 1.66% | +41.0% |
| Q1 2015 | $5,121,000 | +250.0% | 5,878,855 | +282.6% | 1.18% | +193.3% |
| Q4 2014 | $1,463,000 | – | 1,536,750 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 5,878,855 | $5,121,000 | 1.18% |
| DAFNA Capital Management LLC | 717,200 | $687,000 | 0.53% |